Yahoo
Shanghai - Delayed Quote CNY

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)

41.05 -0.72 (-1.72%)
At close: October 30 at 3:00:01 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,302,703.95
1,331,390.25
1,349,755.30
1,117,120.75
1,170,512.90
Cost of Revenue
314,329.15
329,515.50
338,445.88
223,274.09
196,003.28
Gross Profit
988,374.80
1,001,874.75
1,011,309.43
893,846.66
974,509.62
Operating Expense
775,750.77
749,314.17
789,658.36
686,633.94
748,402.42
Operating Income
212,624.04
252,560.58
221,651.07
207,212.72
226,107.21
Net Non Operating Interest Income Expense
5,449.35
10,485.66
14,158.29
11,152.26
10,207.55
Pretax Income
264,497.55
299,651.03
252,588.31
241,639.66
261,988.32
Tax Provision
34,069.22
26,077.16
14,354.15
15,065.24
15,467.56
Net Income Common Stockholders
272,515.05
284,059.38
238,234.16
226,574.42
246,520.76
Basic EPS
1.58
1.63
1.36
1.28
1.39
Diluted EPS
1.58
1.63
1.36
1.28
1.39
Basic Average Shares
172,558.41
174,269.56
175,172.18
177,011.27
176,773.42
Diluted Average Shares
172,558.41
174,269.56
175,172.18
177,011.27
176,773.42
Total Operating Income as Reported
278,989.86
314,630.25
251,980.46
241,736.98
260,628.03
Rent Expense Supplemental
6,846.03
6,933.05
6,666.03
8,204.19
6,590.38
Total Expenses
1,090,079.92
1,078,829.67
1,128,104.24
909,908.03
944,405.69
Net Income from Continuing & Discontinued Operation
272,515.05
284,059.38
238,234.16
226,574.42
246,520.76
Normalized Income
254,898.59
272,188.87
232,415.63
214,893.33
231,062.32
Interest Income
9,201.07
13,104.57
17,541.46
14,696.06
12,841.47
Interest Expense
2,248.70
2,513.01
3,682.76
3,417.92
2,606.04
Net Interest Income
5,449.35
10,485.66
14,158.29
11,152.26
10,207.55
EBIT
266,746.24
302,164.04
256,271.07
245,057.58
264,594.36
EBITDA
266,746.24
394,776.46
339,107.12
318,289.39
322,943.10
Reconciled Cost of Revenue
314,329.15
329,515.50
338,445.88
223,274.09
196,003.28
Reconciled Depreciation
83,194.95
92,612.42
82,836.05
73,231.81
58,348.74
Net Income from Continuing Operation Net Minority Interest
272,515.05
284,059.38
238,234.16
226,574.42
246,520.76
Total Unusual Items Excluding Goodwill
20,221.09
13,002.01
6,169.11
12,457.78
16,428.36
Total Unusual Items
20,221.09
13,002.01
6,169.11
12,457.78
16,428.36
Normalized EBITDA
246,525.16
381,774.45
332,938.01
305,831.61
306,514.74
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
2,604.62
1,131.50
350.58
776.69
969.92
12/31/2022 - 9/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: